| MeSH term | MeSH ID | Detail |
|---|---|---|
| Starvation | D013217 | 47 associated lipids |
| Tuberculosis, Multidrug-Resistant | D018088 | 6 associated lipids |
Total
2
D-cycloserine
D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.
Cross Reference
Introduction
To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with D-cycloserine?
D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with D-cycloserine
PubChem Associated disorders and diseases
What pathways are associated with D-cycloserine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with D-cycloserine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with D-cycloserine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with D-cycloserine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with D-cycloserine?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with D-cycloserine?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with D-cycloserine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Santa Ana EJ et al. | D-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence. | 2015 | Am J Addict | pmid:25808169 |
| Price KL et al. | D-cycloserine and cocaine cue reactivity: preliminary findings. | 2009 | Am J Drug Alcohol Abuse | pmid:20014913 |
| Hofmann SG et al. | Effects of D-cycloserine on craving to alcohol cues in problem drinkers: preliminary findings. | 2012 | Am J Drug Alcohol Abuse | pmid:21851195 |
| Peloquin CA and Berning SE | Advice on treatment of drug-resistant tuberculosis. | 1997 | Am J Health Syst Pharm | pmid:9075505 |
| Goff DC et al. | D-cycloserine added to clozapine for patients with schizophrenia. | 1996 | Am J Psychiatry | pmid:8942463 |
| Shim SS et al. | D-cycloserine augmentation for behavioral therapy. | 2008 | Am J Psychiatry | pmid:18676606 |
| Heresco-Levy U et al. | Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. | 2002 | Am J Psychiatry | pmid:11870017 |
| Kantrowitz JT et al. | d-Cycloserine, an NMDA Glutamate Receptor Glycine Site Partial Agonist, Induces Acute Increases in Brain Glutamate Plus Glutamine and GABA Comparable to Ketamine. | 2016 | Am J Psychiatry | pmid:27903101 |
| Buchanan RW et al. | The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. | 2007 | Am J Psychiatry | pmid:17898352 |
| Goff DC et al. | Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. | 1995 | Am J Psychiatry | pmid:7625475 |